TY - JOUR KW - Cell mediated immunity KW - epidermodysplasia KW - leprosy AU - Tripathy D AU - Neema S AU - Kinra P AU - Sinha P AB -
Epidermodysplasia verruciformis (EDV) is a rare, autosomal recessive, genetic disorder of immune dysregulation characterized by increased susceptibility to cutaneous human papilloma virus infections. It was first described by Lewandowsky and Lutz in 1922 as a form of epidermal nevus. Its association with skin cancers was proposed by Sullivan and Ellis in 1939. Initial lesions often occur in childhood and are of two types; lifelong eruptions of pityriasis versicolor like lesions and flat wart like papules. The latter is characterized by malignant transformation in 35%-50% of patients especially after 40-50 years of age. Bowen disease is the most common tumor followed by invasive squamous cell carcinoma, however, metastasis is rarely encountered.
BT - International journal of mycobacteriology C1 - https://www.ncbi.nlm.nih.gov/pubmed/34558478 DA - 01/2021 DO - 10.4103/ijmy.ijmy_19_21 IS - 2 J2 - Int J Mycobacteriol LA - eng N2 -Epidermodysplasia verruciformis (EDV) is a rare, autosomal recessive, genetic disorder of immune dysregulation characterized by increased susceptibility to cutaneous human papilloma virus infections. It was first described by Lewandowsky and Lutz in 1922 as a form of epidermal nevus. Its association with skin cancers was proposed by Sullivan and Ellis in 1939. Initial lesions often occur in childhood and are of two types; lifelong eruptions of pityriasis versicolor like lesions and flat wart like papules. The latter is characterized by malignant transformation in 35%-50% of patients especially after 40-50 years of age. Bowen disease is the most common tumor followed by invasive squamous cell carcinoma, however, metastasis is rarely encountered.
PY - 2021 SP - 210 EP - 213 T2 - International journal of mycobacteriology TI - Lepromatous leprosy in a case of epidermodysplasia verruciformis - A coincidence or a result of defective cell-mediated immunity? UR - https://www.ijmyco.org/temp/IntJMycobacteriol102210-3371611_092156.pdf VL - 10 SN - 2212-554X ER -